Summit Therapeutics (SMMT) Non Operating Interest Expenses (2017 - 2024)
Summit Therapeutics' Non Operating Interest Expenses was $9,000 in Q4 2024, down 99.6% from the prior quarter.
Powered by 
Analysis
Summit Therapeutics (SMMT) Non Operating Interest Expenses (2017 - 2024) Analysis & Trends
For FY2024, Non Operating Interest Expenses at Summit Therapeutics came in at $8.69 million, down 47.2% from FY2023.
- Non Operating Interest Expenses shows a five-year compound annual growth rate of 97.2% (FY2019 to FY2024).
- In earlier years, Non Operating Interest Expenses was $16.46 million in FY2023 (+274.0%) and $4.4 million in FY2022.
- The Q4 2024 figure marks the lowest quarterly Non Operating Interest Expenses since Q4 2018.
- Per Business Quant data, SMMT's Non Operating Interest Expenses in the three quarters before Q4 2024 was $2.45 million (Q3 2024), $3.1 million (Q2 2024) and $3.12 million (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Summit Therapeutics | 12.28 Bn | 10.04 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | 2.45 Mn |
| Jun 30, 2024 | 3.10 Mn |
| Mar 31, 2024 | 3.12 Mn |
| Mar 31, 2020 | 66,656.98 |
| Dec 31, 2019 | 54,000.45 |
| Oct 31, 2019 | 77,974.45 |
| Jul 31, 2019 | 78,607.28 |
| Mar 31, 2019 | 78,112.39 |
| Jan 31, 2019 | -257,664.14 |
| Oct 31, 2018 | 77,913.87 |
| Jul 31, 2018 | 199,902.57 |
| Apr 30, 2018 | 280,342.97 |
| Oct 31, 2017 | 295,947.52 |
| Jul 31, 2017 | 282,588.17 |
| Apr 30, 2017 | 279,592.04 |
API Access
Summit Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=SMMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "SMMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=SMMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();